EP Patent

EP1227808B1 — Verwendung von treosulfan zur konditionierung von patienten vor knochenmarktransplantation oder blutstammzelltransplantation

Assigned to Medac Gesellschaft fuer Klinische Spezialpraeparate mbH · Expires 2003-10-08 · 23y expired

What this patent protects

Patent listed against Trecondi.

Drugs covered by this patent

Patent Metadata

Patent number
EP1227808B1
Jurisdiction
EP
Classification
—
Expires
2003-10-08
Drug substance claim
No
Drug product claim
No
Assignee
Medac Gesellschaft fuer Klinische Spezialpraeparate mbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.